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Abstract
A limited number of sclerosing
Angiomatoid Nodular Transformation
(SANT) have been reported in pediatric age.
We describe the first case of SANT
occurring in a nine-week-old female infant
that was admitted to our unit for severe
abdominal distension and rectal bleeding.
Enlarged spleen was detected on physical
examination. Laboratory investigations
revealed severe anemia and coagulation
abnormalities. Abdominal ultrasound and
computed tomography revealed ascites and
splenomegaly with a large mass at the lower
medial splenic pole. A diagnosis of intra-
abdominal hemorrhage was presumed and
an exploratory laparotomy was performed.
A complete transformation of the giant
splenomegaly to bossellated masses and
multiple bleeding capsular ruptures without
subcapsular hematoma were found and an
urgent splenectomy was performed. At
histology, a SANT was diagnosed (CD34,
CD31, CD8 positivity). The postoperative
follow up was uneventful. SANT may also
occur in infancy with a potentially life-
threatening presentation. Splenectomy may
represent the only treatment in severe cases. 
Introduction
Sclerosing Angiomatoid Nodular
Transformation (SANT) is a rare, benign,
entity of the spleen characterized by
prominent vascular proliferation associated
with sclerosis. Although its etiology remains
unknown, SANT predominantly effects
females, usually affecting middle-aged
adults.1,2 Most lesions are found incidentally
upon imaging carried out for other causes,
whereas some patients may present with
abdominal pain. To date, a limited number
of pediatric cases have been reported.3-6
We describe the first case of SANT
occurring in an infant and presenting with a
severely distended abdomen, splenomegaly,
anemia, coagulation abnormalities and rectal
bleeding. A review of the literature regarding
SANT pediatric cases is also reported.
Case Report
A nine-week-old female infant, with an
unremarkable birth-medical history, was
admitted to the Pediatric Surgery
Department for severe abdominal distension
and rectal bleeding. Three days prior to
admission the mother noted poor feeding,
diarrhea and vomiting. The infant’s
condition worsened one day before hospital
admission, with the appearance of
progressive abdominal distention and rectal
bleeding. The infant was born at term
(weight 3.200 kg) by cesarean section (CS)
(due to a previous maternal CS). No
antenatal concerns or postnatal medical
problems were reported; however, the
mother reported a family history of
Mediterranean anemia and maternal
diabetes.
Abdominal distension (Figure 1) and an
enlarged spleen (more than 5 cm below the
costal arch) were detected upon physical
examination. The baby (weight 5.5 kg) looked
markedly pale, and was afebrile (36°C);
eupneic (54 breaths/minute) with good
oxygen saturation at room air (99%), the heart
rate was 160 beats/minute with hypertension
(105/52 mmHg). Laboratory investigations
revealed severe anemia (Hb 4.6 g/dL),
thrombocytopenia (54×103/µL) and
coagulation abnormalities: fibrinogen 50
mg/dL vn 150-45 and prothrombin time (PT)
15.7 sec vn 9-12.5; PT% 60 vn 70-120. Liver
function tests were normal. A plain abdominal
X-ray revealed multiple air fluid levels in the
distended small intestine. Abdominal
ultrasound showed ascites and splenomegaly
(11 cm in longitudinal diameter) with a
bossellated mass in the lower part of spleen.
Computed tomography (CT) revealed
corpuscolated liquid in the abdominal cavity,
hepatomegaly and splenomegaly
(longitudinal diameter 9.5 cm) with a large
isodense mass, without intraparenchymal
contrast enhancement, at the lower medial
pole of the spleen (Figure 1).
Based on the triad of pallor, anemia and
abdominal distension, in addition to the
imaging and biochemical findings a
diagnosis of intra-abdominal hemorrhage
was hypothesized. The infant received
several blood transfusions and underwent
monitoring for 24 hours in the Pediatric
Intensive Care Unit. The subsequent increase
in abdominal distension, appearance of
respiratory distress, and persistent abdominal
hemorrhage un-responsive to blood
transfusions were then considered
indications for an exploratory laparotomy.7
During surgery, a great amount of bloody
ascites (more than 1.5 L) were aspirated.
Considering the complete transformation of
the spleen to bosselated masses of different
dimensions (varying from 1 to 2 cm in
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diameter) and the multiple bleeding capsular
ruptures without subcapsular hematoma an
urgent splenectomy was performed.
At gross pathologic evaluation the lesion
was composed of multiple red-brown
nodules diffusely distributed, without a
coalescent scar. At histological evaluation
the mass showed a multinodular architecture
composed of numerous, convoluted,
congested vessels without significant atypia
of the endothelium. Subtle sclerotic tissue
surrounded the vascular structures and an
abundant lymphoid infiltrate was
intermingled among the vessels. By
immunohistochemistry, endothelial cells
expressed the vascular markers CD34 and
CD31 and positivity for CD8, whereas
podoplanin (D2 40), CD21, CD35 e CD 68
were negative. Smooth muscle actin (SMA)
stained the perimeter of the vascular
structures. No infection by HHV8/ORF73 or
EBV/EBER and IGg4 were detected by
immunohistochemistry and in situ
hybridization, respectively (Figure 2). The
lymphoid infiltrate contained both CD20-
positive B and CD3-positive T cell
components with no evidence of
lymphoproliferative disease.
Elevated polymorphonuclear leukocyte
counts were detected after splenectomy;
however, no infectious complications
occurred and the monthly postoperative
follow up has been uneventful. Vaccination
against the most common pathogens that can
cause post-splenectomy infection and
antibiotic prophylaxis were prescribed,
together with parental education on the
consequences of splenectomy.
Discussion and Conclusions
SANT of the spleen is a benign, non-
hematolymphoid tumor that arises in the red
pulp of the spleen (Tracher, Abbot).8,9
Since its first description in 2004 by Martel
et al.,2 155 cases of SANT have been
reported in adults (Cipolla, cao),10,11 while
only four cases have been reported in
pediatric patients (Table 1). Zhang et al.6
described a 3-year-old child injured in a car
accident with a postsplenectomy SANT
diagnosis; Vyas et al.4 presented a case of
SANT with inflammatory pseudotumor-like
areas in an 11-year-old child with a history
of trauma presenting with a rapidly growing
splenic lesion; Agrawal et al.3 described
SANT in a 12-year-old girl with upper
quadrant discomfort which lasted six
months; Kuybuli et al.5 reported a case of
SANT in an 11-year-old girl with growth
retardation and increased sedimentation rate,
mimicking chronic inflammatory disease.
The present report describes the first
SANT case in infancy. Patients with SANT
are usually asymptomatic or have non-
specific abdominal pain. Most cases are
found incidentally on radiographic
examination or during surgery for an
unrelated condition.12 On the contrary, our
case displayed life-threatening intra-
abdominal bleeding with severe and rapid
abdominal distension and coagulation
abnormalities. This was a particularly
unusual presentation requiring splenectomy
as a life-saving treatment.
The pathogenesis of SANT remains
unclear.1,2 It has been hypothesized that
passive congestion of the splenic pulp
secondary to trauma or unknown causes
leads to sinus endothelial cell damage, fibrin
deposition, and inflammation resulting in
pseudotumor appearance or SANT.2 Other
authors have proposed that SANT represents
a peculiar hamartomatous transformation of
the splenic red pulp in response to
exaggerated non-neoplastic stromal
proliferation.13 Finally, SANT has also been
reported to be associated with Epstein-Barr
virus (EBV) infection,14 and
immunoglobulin (Ig)G4-related sclerosing
disease.15,16 A significantly higher number of
IgG4+ plasma cells and an increased
IgG4/IgG ratio has also been reported in
some studies.15,17,18
In our case, EBV was not found and
although we did not measure serum IgG4
levels, immunochemical staining for IgG4
showed only extremely rare plasma cells.
Therefore, we ruled out the hypothesis of a
SANT IgG4-associated disease.
                             Case Report
Figure 1. Clinical and imaging features. A) severe abdominal distension at admission; B)
large isodense splenic mass and abdominal hemorrhage at computed tomography.
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Considering the patient’s age, the role of
genetic or gestational risk factors, such as
gestational diabetes, cannot be excluded in
the pathogenesis. Considering the early
presentation in our case, a long-term post-
splenectomy follow-up to detect possible
hepatic involvement of SANT over time is
recommended.
The differential diagnosis of SANT
includes consideration of several other
benign as well as malignant vascular lesions
of the spleen, such as hemangioma,
lymphangioma, littoral cell angioma,
hamartoma, lymphangiomas,
hemangioendotheliomas, angiosarcoma and
inflammatory pseudotumor (IPT).19 The
preoperative differential diagnosis to exclude
other splenic tumors or malignant lesions is
difficult.20 A thorough histopathologic
examination and immunohistochemical
analysis are necessary to make a diagnosis
of SANT. The characteristics of SANT with
regard to the immunohistochemical profile
include three distinct types of blood vessels
and endothelial cells stained with CD34,
CD8 or CD31, respectively: i)
CD34+/CD31+/CD8- indicative of capillary
derivation; ii) CD34-/CD31+/CD8+
indicative of splenic sinusoidal lining cell
involvement and iii) CD34-/CD31+/CD8-
indicative of small vein involvement.3,19 The
phenotypic profile of our case suggested a
genetic component.
In our case, splenectomy was the only
curative option for the management of
SANT and is the treatment of choice in
symptomatic patients. SANT patients have a
good prognosis, with no recurrence after
splenectomy. 
In conclusion, SANT may also occur in
infancy and present with potentially life-
threatening conditions. Although
splenectomy increases the patient’s risk for
infection, particularly in neonates, infants
and small children, it represents a life-saving
treatment. In early onset SANT in infants,
long term follow-up is recommended to
detect further multi-organ involvement.
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